Literature DB >> 4303579

Stimulation and suppression of aldosterone secretion in patients with an aldosterone-producing adenoma.

P E Slaton, M Schambelan, E G Biglieri.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1969        PMID： 4303579     DOI： 10.1210/jcem-29-2-239

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN： 0021-972X            Impact factor:   5.958


× No keyword cloud information.
  8 in total

1.  Control of plasma aldosterone in a patient with Conn's syndrome before and during spironolactone medication.

Authors:  H Vetter; W Vetter
Journal:  Klin Wochenschr       Date:  1975-04-15

2.  Activity of [des-aspartyl1]-angiotensin II in primary aldosteronism.

Authors:  R M Carey; C R Ayers; E D Vaughan; M J Peach; S M Herf
Journal:  J Clin Invest       Date:  1979-04       Impact factor: 14.808

3.  [Studies on the autonomy of aldosterone secretion in primary hyperaldosteronism. Diagnosis and differential diagnosis of "Conn's syndrome"].

Authors:  A Helber; W Kaufmann; K A Meurer; B Steiner; F Dürr; M Euchenhofer; H Würz; E Streicher
Journal:  Klin Wochenschr       Date:  1973-04-15

Review 4.  Cellular origin of aldosteronomas.

Authors:  A Ganguly
Journal:  Clin Investig       Date:  1992-05

5.  Circadian rhythm of plasma aldosterone concentration in patients with primary aldosteronism.

Authors:  D C Kem; M H Weinberger; C Gomez-Sanchez; N J Kramer; R Lerman; S Furuyama; C A Nugent
Journal:  J Clin Invest       Date:  1973-09       Impact factor: 14.808

Review 6.  Adrenocortical hypertension.

Authors:  Angelo Capricchione; Nathaniel Winer; James R Sowers
Journal:  Curr Hypertens Rep       Date:  2004-06       Impact factor: 5.369

7.  Difficult-to-control hypertension due to bilateral aldosterone-producing adrenocortical microadenomas associated with a cortisol-producing adrenal macroadenoma.

Authors:  R Morimoto; M Kudo; O Murakami; K Takase; S Ishidoya; Y Nakamura; T Ishibashi; S Takahashi; Y Arai; T Suzuki; H Sasano; S Ito; F Satoh
Journal:  J Hum Hypertens       Date:  2010-05-13       Impact factor: 3.012

8.  Adrenocortical hypertension.

Authors:  Angelo Capricchione; Nathaniel Winer; James R Sowers
Journal:  Curr Urol Rep       Date:  2006-01       Impact factor: 2.862
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.